Back
Parker Hannifin 10K Form
Buy
71
PH
Parker Hannifin
Last Price:
626.33
Seasonality Move:
3.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-03 | 10Q | PH/Parker Hannifin Quarterly |
| 2024-02-06 | 10Q | PH/Parker Hannifin Quarterly |
| 2023-11-07 | 10Q | PH/Parker Hannifin Quarterly |
| 2023-08-24 | 10K | PH/Parker Hannifin Annual |
| 2023-05-05 | 10Q | PH/Parker Hannifin Quarterly |
| 2023-02-07 | 10Q | PH/Parker Hannifin Quarterly |
Receive PH News And Ratings
See the #1 stock for the next 7 days that we like better than PH
PH Financial Statistics
Sales & Book Value
| Annual Sales: | $19.93B |
|---|---|
| Cash Flow: | $1.12B |
| Price / Cash Flow: | 26.62 |
| Annual Sales: | $93.87 |
| Price / Book: | 6.49 |
Profitability
| EPS (TTM): | 21.79000 |
|---|---|
| Net Income (TTM): | $2.84B |
| Gross Margin: | $7.13B |
| Return on Equity: | 25.44% |
| Return on Assets: | 9.6% |
Parker Hannifin Earnings Forecast
Key Parker Hannifin Financial Ratios
- The Gross Profit Margin over the past 41 years for PH is 35.76%.
- The Selling, General & Administrative Expenses for PH have been equal to 16.27% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 17.81% of Operating Income.
- The Net Earning history of PH is 14.27% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 26 years.
Parker Hannifin Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | PH |
| CUSIP: | 701094 |
| Website: | parker.com |
Debt
| Debt-to-Equity Ratio: | 0.87 |
|---|---|
| Current Ratio: | 0.93 |
| Quick Ratio: | 0.49 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.89 |
|---|---|
| Forward P/E Ratio: | 20.68 |
PH Technical Analysis vs Fundamental Analysis
Buy
71
Parker Hannifin (PH)
is a Buy
Is Parker Hannifin a Buy or a Sell?
-
Parker Hannifin stock is rated a Buy
The current Parker Hannifin [PH] share price is $609.03. The Score for PH is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.